CompletedNot Applicable

Impact of Ultra-Early Intracranial Aneurysm Treatment in SAH

China293 participantsStarted 2019-11-01

Plain-language summary

This is the first prospective study in Hong Kong that recruit patients with poor neurological status after intracranial aneurysm rupture in all seven public neurosurgical services in Hong Kong. This study assesses whether ultra-early aneurysm treatment improves outcomes in patients with poor neurological status after intracranial aneurysm rupture in Hong Kong. These data are essential to understand the impact of the disease and for future service development in Hong Kong.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Adult patients (aged \>18 years) with spontaneous subarachnoid hemorrhage
✓. Admission into Hospital Authority neurosurgical services
✓. The Glasgow Coma Scale on admission ≤12 (World Federation of Neurosurgical Societies Grade 4-5)

Exclusion criteria

✕. Patients are likely to leave Hong Kong shortly after episode
✕. Patients (or next-of-kin as appropriate) refuse to participate into the study

What they're measuring

Modified Rankin Scale

Timeframe: 6 months

Trial details

NCT IDNCT03894202

SponsorChinese University of Hong Kong

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2023-03-31

View on ClinicalTrials.gov More Subarachnoid Hemorrhage trials